|
YARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.55768797439305E-12 |
| Normal-vs-Stage2 |
2.702700E-03 |
| Normal-vs-Stage3 |
1.97916999999936E-05 |
| Normal-vs-Stage4 |
7.098100E-03 |
| Stage1-vs-Stage2 |
8.462600E-01 |
| Stage1-vs-Stage3 |
2.221800E-02 |
| Stage1-vs-Stage4 |
9.625700E-02 |
| Stage2-vs-Stage3 |
9.255900E-02 |
| Stage2-vs-Stage4 |
2.339400E-01 |
| Stage3-vs-Stage4 |
7.759000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.01990004908981E-09 |
| Normal-vs-Asian |
7.446300E-02 |
| Caucasian-vs-AfricanAmerican |
9.308000E-01 |
| Caucasian-vs-Asian |
2.264800E-01 |
| AfricanAmerican-vs-Asian |
2.304600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.45069511958695E-11 |
| Male-vs-Female |
5.624000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.57749999998946E-06 |
| Normal-vs-Extreme_Weight |
4.20510000154195E-08 |
| Normal-vs-Obese |
1.93680000037944E-07 |
| Normal-vs-Extreme_Obese |
4.923500E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.233800E-01 |
| Normal_Weight-vs-Obese |
9.625400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.035400E-01 |
| Extreme_Weight-vs-Obese |
6.630600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.566800E-01 |
| Obese-vs-Extreme_Obese |
6.020200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.56520000000371E-05 |
| Normal-vs-Age(41-60Yrs) |
1.69397829097306E-12 |
| Normal-vs-Age(61-80Yrs) |
4.65849581132716E-12 |
| Normal-vs-Age(81-100Yrs) |
1.887710E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.121800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.758700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.436400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.257000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.067600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.319400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.73305814143987E-12 |
| Normal-VS-Type2 PRCC |
1.66000002632671E-09 |
| Normal-VS-KIRP CIMP |
6.035500E-04 |
| Normal-VS-Unclassified PRCC |
4.54910000002862E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.603000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.362400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.782300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.930420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.974200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.226800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.67799999999985E-05 |
| Normal-vs-N1 |
1.51299999995302E-06 |
| Normal-vs-N2 |
7.671800E-02 |
| N0-vs-N1 |
7.843200E-04 |
| N0-vs-N2 |
1.587840E-01 |
| N1-vs-N2 |
7.613600E-01 |
|
|
